Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.665 USD | +0.30% | -5.13% | +194.69% |
05-09 | Earnings Flash (NKTR) NEKTAR THERAPEUTICS Reports Q1 Revenue $21.6M, vs. Street Est of $15.3M | MT |
05-09 | Transcript : Nektar Therapeutics, Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+194.69% | 305M | |
+38.77% | 728B | |
+33.06% | 603B | |
-5.48% | 360B | |
+19.89% | 332B | |
+1.54% | 279B | |
+16.17% | 244B | |
+7.82% | 207B | |
-5.73% | 205B | |
+5.68% | 164B |
- Stock Market
- Equities
- NKTR Stock
- News Nektar Therapeutics
- Benchmark Upgrades Nektar Therapeutics to Buy From Hold; Price Target is $20